Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Nuclear Medicine

  Free Subscription


Articles published in Ann Nucl Med

Retrieve available abstracts of 195 articles:
HTML format
Text format



Single Articles


    June 2018
  1. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    Publisher Correction to: (18)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1271.
    PubMed     Text format     Abstract available


  2. XU J, Li Y, Xu X, Zhang J, et al
    Clinical application of (99m)Tc-HYNIC-TOC SPECT/CT in diagnosing and monitoring of pancreatic neuroendocrine neoplasms.
    Ann Nucl Med. 2018 Jun 20. pii: 10.1007/s12149-018-1266.
    PubMed     Text format     Abstract available


  3. MOLINA-GARCIA D, Garcia-Vicente AM, Perez-Beteta J, Amo-Salas M, et al
    Intratumoral heterogeneity in (18)F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate.
    Ann Nucl Med. 2018 Jun 5. pii: 10.1007/s12149-018-1253.
    PubMed     Text format     Abstract available


    May 2018
  4. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Correction to: Predictive and prognostic value of (18)F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2018 May 24. pii: 10.1007/s12149-018-1265.
    PubMed     Text format     Abstract available


  5. CHOI JH, Lim I, Noh WC, Kim HA, et al
    Prediction of tumor differentiation using sequential PET/CT and MRI in patients with breast cancer.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1259.
    PubMed     Text format     Abstract available


  6. KAMEI R, Watanabe Y, Sagiyama K, Isoda T, et al
    Optimal monochromatic color combinations for fusion imaging of FDG-PET and diffusion-weighted MR images.
    Ann Nucl Med. 2018 May 23. pii: 10.1007/s12149-018-1263.
    PubMed     Text format     Abstract available


  7. PARVEZ A, Tau N, Hussey D, Maganti M, et al
    (718)F-FDG PET/CT metabolic tumor parameters and radiomics features in aggressive non-Hodgkin's lymphoma as predictors of treatment outcome and survival.
    Ann Nucl Med. 2018 May 12. pii: 10.1007/s12149-018-1260.
    PubMed     Text format     Abstract available


  8. SAUERBECK J, Ishii K, Hosokawa C, Kaida H, et al
    The correlation between striatal and cortical binding ratio of (11)C-PiB-PET in amyloid-uptake-positive patients.
    Ann Nucl Med. 2018 May 5. pii: 10.1007/s12149-018-1258.
    PubMed     Text format     Abstract available


    April 2018
  9. ISHIGUCHI H, Ito S, Kato K, Sakurai Y, et al
    Diagnostic performance of (18)F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ann Nucl Med. 2018 Apr 17. pii: 10.1007/s12149-018-1254.
    PubMed     Text format     Abstract available


  10. IWABUCHI Y, Nakahara T, Kameyama M, Yamada Y, et al
    Quantitative evaluation of the tracer distribution in dopamine transporter SPECT for objective interpretation.
    Ann Nucl Med. 2018 Apr 13. pii: 10.1007/s12149-018-1256.
    PubMed     Text format     Abstract available


    March 2018
  11. BEXELIUS T, Sohlberg A
    Implementation of GPU accelerated SPECT reconstruction with Monte Carlo-based scatter correction.
    Ann Nucl Med. 2018 Mar 21. pii: 10.1007/s12149-018-1252.
    PubMed     Text format     Abstract available


  12. INUI Y, Ichihara T, Uno M, Ishiguro M, et al
    CT-based attenuation correction and resolution compensation for I-123 IMP brain SPECT normal database: a multicenter phantom study.
    Ann Nucl Med. 2018 Mar 19. pii: 10.1007/s12149-018-1248.
    PubMed     Text format     Abstract available


  13. MIZUMURA S, Nishikawa K, Murata A, Yoshimura K, et al
    Improvement in the measurement error of the specific binding ratio in dopamine transporter SPECT imaging due to exclusion of the cerebrospinal fluid fraction using the threshold of voxel RI count.
    Ann Nucl Med. 2018 Mar 15. pii: 10.1007/s12149-018-1249.
    PubMed     Text format     Abstract available


    February 2018
  14. PALARD-NOVELLO X, Blin AL, Bourhis D, Garin E, et al
    Comparison of choline influx from dynamic (18)F-Choline PET/CT and clinicopathological parameters in prostate cancer initial assessment.
    Ann Nucl Med. 2018 Feb 28. pii: 10.1007/s12149-018-1246.
    PubMed     Text format     Abstract available


  15. TSUJIKAWA T, Narita N, Kanno M, Takabayashi T, et al
    Role of PET/MRI in oral cavity and oropharyngeal cancers based on the 8th edition of the AJCC cancer staging system: a pictorial essay.
    Ann Nucl Med. 2018 Feb 27. pii: 10.1007/s12149-018-1244.
    PubMed     Text format     Abstract available


  16. SIMSEK DH, Sanli Y, Kuyumcu S, Basaran B, et al
    (68)Ga-DOTATATE PET-CT imaging in carotid body paragangliomas.
    Ann Nucl Med. 2018 Feb 21. pii: 10.1007/s12149-018-1242.
    PubMed     Text format     Abstract available


  17. ANNUNZIATA S, Cuccaro A, Tisi MC, Hohaus S, et al
    FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Ann Nucl Med. 2018 Feb 20. pii: 10.1007/s12149-018-1243.
    PubMed     Text format     Abstract available


  18. NISHII R, Higashi T, Kagawa S, Okuyama C, et al
    (18)F-FPYBF-2, a new F-18 labelled amyloid imaging PET tracer: biodistribution and radiation dosimetry assessment of first-in-man (18)F-FPYBF-2 PET imaging.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1240.
    PubMed     Text format     Abstract available


  19. TORIIHARA A, Ohtake M, Tateishi K, Hino-Shishikura A, et al
    Prognostic implications of (62)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) PET/CT in patients with glioma.
    Ann Nucl Med. 2018 Feb 16. pii: 10.1007/s12149-018-1241.
    PubMed     Text format     Abstract available


  20. OZDERYA A, Temizkan S, Gul AE, Ozugur S, et al
    Biochemical and pathologic factors affecting technetium-99m-methoxyisobutylisonitrile imaging results in patients with primary hyperparathyroidism.
    Ann Nucl Med. 2018 Feb 5. pii: 10.1007/s12149-018-1239.
    PubMed     Text format     Abstract available


    January 2018
  21. HIGASHI T, Nishii R, Kagawa S, Kishibe Y, et al
    (18)F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.
    Ann Nucl Med. 2018 Jan 31. pii: 10.1007/s12149-018-1236.
    PubMed     Text format     Abstract available


  22. DONG W, Li J, Mi H, Song X, et al
    Relationship between collateral circulation and myocardial viability of (18)F-FDG PET/CT subtended by chronic total occluded coronary arteries.
    Ann Nucl Med. 2018 Jan 29. pii: 10.1007/s12149-018-1234.
    PubMed     Text format     Abstract available


  23. TSUJIMOTO M, Teramoto A, Ota S, Toyama H, et al
    Automated segmentation and detection of increased uptake regions in bone scintigraphy using SPECT/CT images.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1237.
    PubMed     Text format     Abstract available


  24. ARORA G, Bandopadhyaya G
    Paradigm shift in theranostics of neuroendocrine tumors: conceptual horizons of nanotechnology in nuclear medicine.
    Ann Nucl Med. 2018 Jan 27. pii: 10.1007/s12149-018-1235.
    PubMed     Text format     Abstract available


  25. NAKAJIMA K, Okuda K, Matsuo S, Wakabayashi H, et al
    Is (123)I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.
    Ann Nucl Med. 2018 Jan 15. pii: 10.1007/s12149-018-1231.
    PubMed     Text format     Abstract available


  26. GERBAUDO VH, Killoran JH, Kim CK, Hornick JL, et al
    Pilot study of serial FLT and FDG-PET/CT imaging to monitor response to neoadjuvant chemoradiotherapy of esophageal adenocarcinoma: correlation with histopathologic response.
    Ann Nucl Med. 2018 Jan 13. pii: 10.1007/s12149-018-1229.
    PubMed     Text format     Abstract available


    December 2017
  27. KITS A, Martin H, Sanchez-Crespo A, Delgado AF, et al
    Diagnostic accuracy of (11)C-methionine PET in detecting neuropathologically confirmed recurrent brain tumor after radiation therapy.
    Ann Nucl Med. 2017 Dec 26. pii: 10.1007/s12149-017-1227.
    PubMed     Text format     Abstract available


  28. GARCIA-VICENTE AM, Tello-Galan MJ, Amo-Salas M, Ros-Izquierdo J, et al
    Do clinical and laboratory variables have any impact on the diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin?
    Ann Nucl Med. 2017 Dec 20. pii: 10.1007/s12149-017-1226.
    PubMed     Text format     Abstract available


  29. UMEDA T, Koizumi M, Fukai S, Miyaji N, et al
    Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Ann Nucl Med. 2017 Dec 14. pii: 10.1007/s12149-017-1224.
    PubMed     Text format     Abstract available


  30. CHEIMARIOTIS GA, Al-Mashat M, Haris K, Aletras AH, et al
    Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CT.
    Ann Nucl Med. 2017 Dec 13. pii: 10.1007/s12149-017-1223.
    PubMed     Text format     Abstract available


  31. JONES KM, Solnes LB, Rowe SP, Gorin MA, et al
    Use of quantitative SPECT/CT reconstruction in (99m)Tc-sestamibi imaging of patients with renal masses.
    Ann Nucl Med. 2017 Dec 6. pii: 10.1007/s12149-017-1222.
    PubMed     Text format     Abstract available


    November 2017
  32. SATHEKGE M, Garcia-Perez O, Paez D, El-Haj N, et al
    Molecular imaging in musculoskeletal infections with 99mTc-UBI 29-41 SPECT/CT.
    Ann Nucl Med. 2017 Nov 21. doi: 10.1007/s12149-017-1219.
    PubMed     Text format     Abstract available


  33. LI T, Wu NY, Song N, Mok GSP, et al
    Evaluation of sequential SPECT and CT for targeted radionuclide therapy dosimetry.
    Ann Nucl Med. 2017 Nov 15. doi: 10.1007/s12149-017-1218.
    PubMed     Text format     Abstract available


  34. KITAJIMA K, Miyoshi Y, Yamano T, Odawara S, et al
    Prognostic value of FDG-PET and DWI in breast cancer.
    Ann Nucl Med. 2017 Nov 13. doi: 10.1007/s12149-017-1217.
    PubMed     Text format     Abstract available


  35. SANLI Y, Kuyumcu S, Sanli O, Buyukkaya F, et al
    Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer.
    Ann Nucl Med. 2017;31:709-717.
    PubMed     Text format     Abstract available


  36. KURISU S, Sumimoto Y, Ikenaga H, Ishibashi K, et al
    Effects of chronic kidney disease on myocardial washout rate of thallium-201 in patients with normal myocardial perfusion on single photon emission computed tomography.
    Ann Nucl Med. 2017;31:703-708.
    PubMed     Text format     Abstract available


  37. WERNER RA, Sheikhbahaei S, Jones KM, Javadi MS, et al
    Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia.
    Ann Nucl Med. 2017;31:696-702.
    PubMed     Text format     Abstract available


    October 2017
  38. CAMPBELL SP, Baras AS, Ball MW, Kates M, et al
    Low levels of PSMA expression limit the utility of 18F-DCFPyL PET/CT for imaging urothelial carcinoma.
    Ann Nucl Med. 2017 Oct 24. doi: 10.1007/s12149-017-1216.
    PubMed     Text format     Abstract available


  39. AMAKUSA S, Matsuoka K, Kawano M, Hasegawa K, et al
    Influence of region-of-interest determination on measurement of signal-to-noise ratio in liver on PET images.
    Ann Nucl Med. 2017 Oct 20. doi: 10.1007/s12149-017-1215.
    PubMed     Text format     Abstract available


  40. KIRIYAMA T, Fukushima Y, Hayashi H, Takano H, et al
    Feasibility of combined risk stratification with coronary CT angiography and stress myocardial SPECT in patients with chronic coronary artery disease.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1214.
    PubMed     Text format     Abstract available


  41. CAOBELLI F, Chiaravalloti A, Evangelista L, Saladini G, et al
    Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid.
    Ann Nucl Med. 2017 Oct 6. doi: 10.1007/s12149-017-1213.
    PubMed     Text format     Abstract available


  42. MASAKI Y, Shimizu Y, Yoshioka T, Nishijima KI, et al
    FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.
    Ann Nucl Med. 2017;31:596-604.
    PubMed     Text format     Abstract available


    September 2017
  43. NAKAJIMA K, Okuda K, Momose M, Matsuo S, et al
    IQ.SPECT technology and its clinical applications using multicenter normal databases.
    Ann Nucl Med. 2017 Sep 22. doi: 10.1007/s12149-017-1210.
    PubMed     Text format     Abstract available


  44. KROISS AS, Nekolla SG, Dobrozemsky G, Grubinger T, et al
    CT-based SPECT attenuation correction and assessment of infarct size: results from a cardiac phantom study.
    Ann Nucl Med. 2017 Sep 21. doi: 10.1007/s12149-017-1211.
    PubMed     Text format     Abstract available


  45. OKIZAKI A, Nakayama M, Nakajima K, Katayama T, et al
    Inter- and intra-observer reproducibility of quantitative analysis for FP-CIT SPECT in patients with DLB.
    Ann Nucl Med. 2017 Sep 14. doi: 10.1007/s12149-017-1209.
    PubMed     Text format     Abstract available


  46. TSUJIKAWA T, Yamamoto M, Shono K, Yamada S, et al
    Assessment of intratumor heterogeneity in mesenchymal uterine tumor by an 18F-FDG PET/CT texture analysis.
    Ann Nucl Med. 2017 Sep 13. doi: 10.1007/s12149-017-1208.
    PubMed     Text format     Abstract available


  47. GARCIA-VICENTE AM, Molina D, Perez-Beteta J, Amo-Salas M, et al
    Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancer.
    Ann Nucl Med. 2017 Sep 8. doi: 10.1007/s12149-017-1203.
    PubMed     Text format     Abstract available


  48. SUGIHARA T, Koizumi M, Koyama M, Terauchi T, et al
    Bone metastases from breast cancer: associations between morphologic CT patterns and glycolytic activity on PET and bone scintigraphy as well as explorative search for influential factors.
    Ann Nucl Med. 2017 Sep 1. doi: 10.1007/s12149-017-1202.
    PubMed     Text format     Abstract available


    August 2017
  49. TSUJIKAWA T, Rahman T, Yamamoto M, Yamada S, et al
    18F-FDG PET radiomics approaches: comparing and clustering features in cervical cancer.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1199.
    PubMed     Text format     Abstract available


  50. YAMASHITA S, Yamamoto H, Nakaichi T, Yoneyama T, et al
    Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body 18F-fluorodeoxyglucose positron emission tomography with the same acquisition duration.
    Ann Nucl Med. 2017 Aug 16. doi: 10.1007/s12149-017-1200.
    PubMed     Text format     Abstract available


  51. YADA N, Onishi H, Miyai M, Ozasa K, et al
    Effect of resolution recovery using graph plots on regional cerebral blood flow in healthy volunteers.
    Ann Nucl Med. 2017;31:553-562.
    PubMed     Text format     Abstract available


    July 2017
  52. CHEN L, Tsui BMW, Mok GSP
    Design and evaluation of two multi-pinhole collimators for brain SPECT.
    Ann Nucl Med. 2017 Jul 28. doi: 10.1007/s12149-017-1195.
    PubMed     Text format     Abstract available


  53. INUBUSHI M, Kaneta T, Ishimori T, Imabayashi E, et al
    Topics of nuclear medicine research in Europe.
    Ann Nucl Med. 2017 Jul 25. doi: 10.1007/s12149-017-1198.
    PubMed     Text format     Abstract available


  54. ISIK EG, Kuyumcu S, Kebudi R, Sanli Y, et al
    Prediction of outcome in pediatric Hodgkin lymphoma based on interpretation of 18FDG-PET/CT according to DeltaSUVmax, Deauville 5-point scale and IHP criteria.
    Ann Nucl Med. 2017 Jul 24. doi: 10.1007/s12149-017-1196.
    PubMed     Text format     Abstract available


  55. ITO S, Endo A, Okada T, Nakamura T, et al
    Comparison of CTAC and prone imaging for the detection of coronary artery disease using CZT SPECT.
    Ann Nucl Med. 2017 Jul 10. doi: 10.1007/s12149-017-1194.
    PubMed     Text format     Abstract available


  56. HOWARD BA, Morgan R, Thorpe MP, Turkington TG, et al
    Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1192.
    PubMed     Text format     Abstract available


  57. NAKAJIMA K, Okuda K, Yokoyama K, Yoneyama T, et al
    Cross calibration of 123I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1191.
    PubMed     Text format     Abstract available


  58. SANTHOSH S, Mittal BR, Bhasin DK, Rana SS, et al
    Fluorodeoxyglucose-positron emission tomography/computed tomography performs better than contrast-enhanced computed tomography for metastasis evaluation in the initial staging of pancreatic adenocarcinoma.
    Ann Nucl Med. 2017 Jul 8. doi: 10.1007/s12149-017-1193.
    PubMed     Text format     Abstract available


  59. HIGASHI K, Ueda Y, Shimasaki M, Ishigaki Y, et al
    High FDG uptake on PET is associated with negative cell-to-cell adhesion molecule E-cadherin expression in lung adenocarcinoma.
    Ann Nucl Med. 2017 Jul 4. doi: 10.1007/s12149-017-1187.
    PubMed     Text format     Abstract available


  60. ZHENG J, Miao W, Huang C, Lin H, et al
    Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging.
    Ann Nucl Med. 2017;31:486-494.
    PubMed     Text format     Abstract available


    June 2017
  61. CHENG L, Zhang J, Wang Y, Xu X, et al
    Textural features of 18F-FDG PET after two cycles of neoadjuvant chemotherapy can predict pCR in patients with locally advanced breast cancer.
    Ann Nucl Med. 2017 Jun 23. doi: 10.1007/s12149-017-1184.
    PubMed     Text format     Abstract available


  62. SHIDAHARA M, Thomas BA, Okamura N, Ibaraki M, et al
    A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [18F]THK5351 and [11C]PIB.
    Ann Nucl Med. 2017 Jun 21. doi: 10.1007/s12149-017-1185.
    PubMed     Text format     Abstract available


  63. NIKAKI A, Angelidis G, Efthimiadou R, Tsougos I, et al
    18F-fluorothymidine PET imaging in gliomas: an update.
    Ann Nucl Med. 2017 Jun 13. doi: 10.1007/s12149-017-1183.
    PubMed     Text format     Abstract available


  64. ISHIBASHI M, Tanabe Y, Fujii S, Ogawa T, et al
    Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesions.
    Ann Nucl Med. 2017 Jun 5. doi: 10.1007/s12149-017-1182.
    PubMed     Text format     Abstract available


  65. KATAGIRI M, Nakahara T, Murata M, Ogata Y, et al
    Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathy.
    Ann Nucl Med. 2017;31:399-406.
    PubMed     Text format     Abstract available


  66. SHIMIZU S, Hirose D, Namioka N, Kanetaka H, et al
    Correlation between clinical symptoms and striatal DAT uptake in patients with DLB.
    Ann Nucl Med. 2017;31:390-398.
    PubMed     Text format     Abstract available


  67. KUNIKOWSKA J, Pawlak D, Bak MI, Kos-Kudla B, et al
    Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study.
    Ann Nucl Med. 2017;31:347-356.
    PubMed     Text format     Abstract available


    May 2017
  68. IMABAYASHI E, Soma T, Sone D, Tsukamoto T, et al
    Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT.
    Ann Nucl Med. 2017 May 25. doi: 10.1007/s12149-017-1181.
    PubMed     Text format     Abstract available


  69. AKTAN M, Koc M, Kanyilmaz G, Yavuz BB, et al
    Prognostic value of pre-treatment 18F-FDG-PET uptake in small-cell lung cancer.
    Ann Nucl Med. 2017 May 17. doi: 10.1007/s12149-017-1178.
    PubMed     Text format     Abstract available


  70. KIM JW, Seo S, Kim HS, Kim DY, et al
    Erratum to: Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1179.
    PubMed     Text format    


  71. TORIIHARA A, Nakajima R, Arai A, Nakadate M, et al
    Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms.
    Ann Nucl Med. 2017 May 11. doi: 10.1007/s12149-017-1180.
    PubMed     Text format     Abstract available


  72. SUZUKI H, Kato K, Nishio M, Tamaki T, et al
    FDG-PET/CT predicts survival and lung metastasis of hypopharyngeal cancer in a multi-institutional retrospective study.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1176.
    PubMed     Text format     Abstract available


  73. SHIBUTANI T, Onoguchi M, Yoneyama H, Konishi T, et al
    Characteristics of single- and dual-photopeak energy window acquisitions with thallium-201 IQ-SPECT/CT system.
    Ann Nucl Med. 2017 May 3. doi: 10.1007/s12149-017-1177.
    PubMed     Text format     Abstract available


  74. SADEGHZADEH M, Alirezapour B, Charkhlooie GA, Baghery MK, et al
    Radioiodination and preclinical evaluation of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine as a breast tumor imaging tracer in mouse.
    Ann Nucl Med. 2017;31:335-346.
    PubMed     Text format     Abstract available


  75. MOSLEMI V, Ashoor M
    Design and performance evaluation of a new high energy parallel hole collimator for radioiodine planar imaging by gamma cameras: Monte Carlo simulation study.
    Ann Nucl Med. 2017;31:324-334.
    PubMed     Text format     Abstract available


    April 2017
  76. KOIZUMI M, Motegi K, Koyama M, Terauchi T, et al
    Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups.
    Ann Nucl Med. 2017 Apr 29. doi: 10.1007/s12149-017-1175.
    PubMed     Text format     Abstract available


  77. WENG CC, Huang SL, Chen ZA, Lin KJ, et al
    [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease.
    Ann Nucl Med. 2017 Apr 27. doi: 10.1007/s12149-017-1174.
    PubMed     Text format     Abstract available


  78. KIM JW, Seo S, Kim HS, Kim DY, et al
    Comparative evaluation of the algorithms for parametric mapping of the novel myocardial PET imaging agent 18F-FPTP.
    Ann Nucl Med. 2017 Apr 25. doi: 10.1007/s12149-017-1171.
    PubMed     Text format     Abstract available


  79. WATABE T, Hanaoka K, Naka S, Kanai Y, et al
    Practical calculation method to estimate the absolute boron concentration in tissues using 18F-FBPA PET.
    Ann Nucl Med. 2017 Apr 24. doi: 10.1007/s12149-017-1172.
    PubMed     Text format     Abstract available


  80. KONISHI T, Nakajima K, Okuda K, Yoneyama H, et al
    IQ-SPECT for thallium-201 myocardial perfusion imaging: effect of normal databases on quantification.
    Ann Nucl Med. 2017 Apr 12. doi: 10.1007/s12149-017-1170.
    PubMed     Text format     Abstract available


  81. YAMAMOTO H, Arimura S, Nakanishi A, Shimo Y, et al
    Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT.
    Ann Nucl Med. 2017 Apr 5. doi: 10.1007/s12149-017-1168.
    PubMed     Text format     Abstract available


  82. HASHIMOTO T, Yokota C, Koshino K, Temma T, et al
    Binding of 11C-Pittsburgh compound-B correlated with white matter injury in hypertensive small vessel disease.
    Ann Nucl Med. 2017;31:227-234.
    PubMed     Text format     Abstract available


  83. KURISU S, Higaki T, Sumimoto Y, Ikenaga H, et al
    Aortic knob width reflects left ventricular diastolic function assessed by gated myocardial perfusion single photon emission computed tomography in patients with normal myocardial perfusion.
    Ann Nucl Med. 2017;31:245-249.
    PubMed     Text format     Abstract available


  84. GENDRE R, Lairez O, Mondoly P, Duparc A, et al
    Research of predictive factors for cardiac resynchronization therapy: a prospective study comparing data from phase-analysis of gated myocardial perfusion single-photon computed tomography and echocardiography : Trying to anticipate response to CRT.
    Ann Nucl Med. 2017;31:218-226.
    PubMed     Text format     Abstract available


  85. MIKI T, Shimada H, Kim JS, Yamamoto Y, et al
    Brain uptake and safety of Flutemetamol F 18 injection in Japanese subjects with probable Alzheimer's disease, subjects with amnestic mild cognitive impairment and healthy volunteers.
    Ann Nucl Med. 2017;31:260-272.
    PubMed     Text format     Abstract available


  86. MISAKA T, Hosono M, Kudo T, Ito T, et al
    Influence of acquisition orbit on phase analysis of gated single photon emission computed tomography myocardial perfusion imaging for assessment of left ventricular mechanical dyssynchrony.
    Ann Nucl Med. 2017;31:235-244.
    PubMed     Text format     Abstract available


  87. WATANABE S, Nakajima K, Mizokami A, Yaegashi H, et al
    Bone scan index of the jaw: a new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis.
    Ann Nucl Med. 2017;31:201-210.
    PubMed     Text format     Abstract available


    March 2017
  88. SINGNURKAR A, Poon R, Metser U
    Comparison of 18F-FDG-PET/CT and 18F-FDG-PET/MR imaging in oncology: a systematic review.
    Ann Nucl Med. 2017 Mar 28. doi: 10.1007/s12149-017-1164.
    PubMed     Text format     Abstract available


  89. KROISS AS, Uprimny C, Shulkin BL, Frech A, et al
    Compared to 123I-MIBG SPECT/CT, 18F-DOPA PET/CT provides accurate tumor extent in patients with extra-adrenal paraganglioma.
    Ann Nucl Med. 2017 Mar 27. doi: 10.1007/s12149-017-1162.
    PubMed     Text format     Abstract available


  90. MANOHARAN V, Lee S, Chong S, Yap J, et al
    Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
    Ann Nucl Med. 2017 Mar 15. doi: 10.1007/s12149-017-1159.
    PubMed     Text format     Abstract available


  91. ARENTSON-LANTZ EJ, Saeed IH, Frassetto LA, Masharani U, et al
    11C-L-methyl methionine dynamic PET/CT of skeletal muscle: response to protein supplementation compared to L-[ring 13C6] phenylalanine infusion with serial muscle biopsy.
    Ann Nucl Med. 2017 Mar 4. doi: 10.1007/s12149-017-1157.
    PubMed     Text format     Abstract available


    February 2017
  92. ISLAM MM, Tsujikawa T, Mori T, Kiyono Y, et al
    Pixel-by-pixel precise delay correction for measurement of cerebral hemodynamic parameters in H215O PET study.
    Ann Nucl Med. 2017 Feb 27. doi: 10.1007/s12149-017-1156.
    PubMed     Text format     Abstract available


  93. OGATA Y, Nakahara T, Ode K, Matsusaka Y, et al
    3D SPECT/CT fusion using image data projection of bone SPECT onto 3D volume-rendered CT images: feasibility and clinical impact in the diagnosis of bone metastasis.
    Ann Nucl Med. 2017 Feb 27. doi: 10.1007/s12149-017-1158.
    PubMed     Text format     Abstract available


  94. TAKAHASHI M, Soma T, Mukasa A, Koyama K, et al
    An automated voxel-based method for calculating the reference value for a brain tumour metabolic index using 18F-FDG-PET and 11C-methionine PET.
    Ann Nucl Med. 2017 Feb 13. doi: 10.1007/s12149-017-1153.
    PubMed     Text format     Abstract available


  95. ITO H, Ikoma Y, Seki C, Kimura Y, et al
    Visual evaluation of kinetic characteristics of PET probe for neuroreceptors using a two-phase graphic plot analysis.
    Ann Nucl Med. 2017 Feb 8. doi: 10.1007/s12149-017-1155.
    PubMed     Text format     Abstract available


  96. WON KS, Kim DH, Sung DH, Song BI, et al
    Clinical correlation of metabolic parameters on 18F-FDG PET/CT in idiopathic frozen shoulder.
    Ann Nucl Med. 2017 Feb 6. doi: 10.1007/s12149-016-1147.
    PubMed     Text format     Abstract available


  97. CHONO T, Onoguchi M, Shibutani T, Hashimoto A, et al
    Improvement in automated quantitation of myocardial perfusion abnormality by using iterative reconstruction image in combination with resolution recovery, attenuation and scatter corrections for the detection of coronary artery disease.
    Ann Nucl Med. 2017;31:181-189.
    PubMed     Text format     Abstract available


  98. NAKAJIMA R, Abe K, Momose M, Fukushima K, et al
    Optimization of scan initiation timing after 11C-methionine administration for the diagnosis of suspected recurrent brain tumors.
    Ann Nucl Med. 2017;31:190-197.
    PubMed     Text format     Abstract available


  99. LASNON C, Salomon T, Desmonts C, Do P, et al
    Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
    Ann Nucl Med. 2017;31:125-134.
    PubMed     Text format     Abstract available


  100. KATAOKA S, Momose M, Fukushima K, Serizawa N, et al
    Regional myocardial damage and active inflammation in patients with cardiac sarcoidosis detected by non-invasive multi-modal imaging.
    Ann Nucl Med. 2017;31:135-143.
    PubMed     Text format     Abstract available


    January 2017
  101. MITAMURA K, Yamamoto Y, Kudomi N, Maeda Y, et al
    Intratumoral heterogeneity of 18F-FLT uptake predicts proliferation and survival in patients with newly diagnosed gliomas.
    Ann Nucl Med. 2017;31:46-52.
    PubMed     Text format     Abstract available


    December 2016
  102. ZHANG D, Yang BH, Wu NY, Mok GS, et al
    Respiratory average CT for attenuation correction in myocardial perfusion SPECT/CT.
    Ann Nucl Med. 2016 Dec 20. doi: 10.1007/s12149-016-1144.
    PubMed     Text format     Abstract available


  103. ABADI P, Johansen A, Godballe C, Gerke O, et al
    18F-FDG PET/CT to differentiate malignant necrotic lymph node from benign cystic lesions in the neck.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  104. SOLTANI M, Sefidgar M, Bazmara H, Casey ME, et al
    Spatiotemporal distribution modeling of PET tracer uptake in solid tumors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  105. AKAMATSU G, Ohnishi A, Aita K, Nishida H, et al
    A revisit to quantitative PET with 18F-FDOPA of high specific activity using a high-resolution condition in view of application to regenerative therapy.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  106. FUJII H, Nakadate M, Tanaka H, Harata N, et al
    Residual FDG uptake of primary thyroid lymphoma after treatment may overestimate residual lymphoma.
    Ann Nucl Med. 2016;30:756-759.
    PubMed     Text format     Abstract available


  107. KIM YD, Jeong HS, Song IU, Chung YA, et al
    Brain perfusion alterations in depressed patients with Parkinson's disease.
    Ann Nucl Med. 2016;30:731-737.
    PubMed     Text format     Abstract available


  108. SAZONOVA SI, Ilyushenkova JN, Lishmanov YB, Batalov RE, et al
    Assessment of radiological techniques application possibility for non-invasive diagnostics of latent inflammatory processes in myocardium in patients with atrial fibrillation.
    Ann Nucl Med. 2016;30:738-748.
    PubMed     Text format     Abstract available


    November 2016
  109. CHO SG, Park KS, Kim J, Kang SR, et al
    Coronary flow reserve and relative flow reserve measured by N-13 ammonia PET for characterization of coronary artery disease.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  110. METSER U, Halankar J, Langer D, Mohan R, et al
    Effect of chemotherapy on the impact of FDG-PET/CT in selection of patients for surgical resection of colorectal liver metastases: single center analysis of PET-CAM randomized trial.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  111. ELISEI F, Crivellaro C, Giuliani D, Dolci C, et al
    Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  112. LAIREZ O, Agostini D
    One year of nuclear cardiology in Europe.
    Ann Nucl Med. 2016;30:594-599.
    PubMed     Text format    


    October 2016
  113. ISHIWATA K, Hayashi K, Sakai M, Kawauchi S, et al
    Determination of radionuclides and radiochemical impurities produced by in-house cyclotron irradiation and subsequent radiosynthesis of PET tracers.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  114. ISODA T, BaBa S, Maruoka Y, Kitamura Y, et al
    Impact of patient age on the iodine/FDG "flip-flop" phenomenon in lung metastasis from thyroid cancer.
    Ann Nucl Med. 2016;30:518-24.
    PubMed     Text format     Abstract available


  115. DOS ANJOS DA, Habr-Gama A, Vailati BB, Rossi CB, et al
    (18)F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes.
    Ann Nucl Med. 2016;30:513-7.
    PubMed     Text format     Abstract available


    September 2016
  116. URANO M, Maki Y, Nishikawa H, Kawai T, et al
    Diagnostic utility of a computer-aided diagnosis system for whole-body bone scintigraphy to detect bone metastasis in breast cancer patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  117. SHANDIZ MS, Rad HS, Ghafarian P, Karam MB, et al
    MR-guided attenuation map for prostate PET-MRI: an intensity and morphologic-based segmentation approach for generating a five-class attenuation map in pelvic region.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  118. HOSHIKAWA H, Mori T, Maeda Y, Takahashi S, et al
    Influence of volumetric 4'-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  119. YOO J, Yoon HJ, Kim BS
    Prognostic value of primary tumor SUVmax on F-18 FDG PET/CT compared with semi-quantitative tumor uptake on Tc-99m sestamibi breast-specific gamma imaging in invasive ductal breast cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  120. CARRIO I, Kinuya S
    New section in EJNMMI and Annals of Nuclear Medicine.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  121. KIM J, Lee JO, Paik JH, Lee WW, et al
    Different predictive values of interim 18F-FDG PET/CT in germinal center like and non-germinal center like diffuse large B-cell lymphoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  122. SHIMOSEGAWA E, Isohashi K, Naka S, Horitsugi G, et al
    Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    August 2016
  123. CHOI WH, Um YH, Jung WS, Kim SH, et al
    Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  124. SUZAWA N, Ichikawa Y, Ishida M, Tomita Y, et al
    Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  125. SHIBUTANI T, Onoguchi M, Katafuchi T, Kinuya S, et al
    Development of a myocardial phantom and analysis system toward the standardization of myocardial SPECT image across institutions.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  126. SAKATANI T, Shimoo S, Takamatsu K, Kyodo A, et al
    Usefulness of the novel risk estimation software, Heart Risk View, for the prediction of cardiac events in patients with normal myocardial perfusion SPECT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  127. IBARAKI M, Matsubara K, Sato K, Mizuta T, et al
    Validation of a simplified scatter correction method for 3D brain PET with 15O.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  128. SHIBA H, Takahashi A, Baba S, Himuro K, et al
    Analysis of the influence of 111In on 90Y-bremsstrahlung SPECT based on Monte Carlo simulation.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  129. HUANG YE, Huang YJ, Ko M, Hsu CC, et al
    Dual-time-point 18F-FDG PET/CT in the diagnosis of solitary pulmonary lesions in a region with endemic granulomatous diseases.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  130. KURISU S, Sumimoto Y, Ikenaga H, Watanabe N, et al
    Effects of left ventricular size on the accuracy of diastolic parameters derived from myocardial perfusion SPECT: comparison with tissue Doppler echocardiography.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  131. HELALI M, Addeo P, Heimburger C, Detour J, et al
    Carbidopa-assisted 18F-fluorodihydroxyphenylalanine PET/CT for the localization and staging of non-functioning neuroendocrine pancreatic tumors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  132. OTOMI Y, Shinya T, Otsuka H, Terazawa K, et al
    Increased (18)F-fluorodeoxyglucose accumulation in bilateral adrenal glands of the patients suffering from vasovagal reaction due to blood vessel puncture.
    Ann Nucl Med. 2016;30:501-5.
    PubMed     Text format     Abstract available


  133. CHIANG KF, Cheng CM, Tsai SC, Lin WY, et al
    Relationship of myocardial substrate characteristics as assessed by myocardial perfusion imaging and cardiac reverse remodeling levels after cardiac resynchronization therapy.
    Ann Nucl Med. 2016;30:484-93.
    PubMed     Text format     Abstract available


    July 2016
  134. NONOKUMA M, Kuwabara Y, Hida K, Tani T, et al
    Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  135. KONDO A, Ishii H, Aoki S, Suzuki M, et al
    Phase IIa clinical study of [18F]fluciclovine: efficacy and safety of a new PET tracer for brain tumors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  136. LEE SH, Jin S, Lee HS, Ryu JS, et al
    Metformin discontinuation less than 72 h is suboptimal for F-18 FDG PET/CT interpretation of the bowel.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  137. CASTELLANI M, Vadrucci M, Florimonte L, Caronni M, et al
    18F-FDG uptake in main arterial branches of patients with large vessel vasculitis: visual and semiquantitative analysis.
    Ann Nucl Med. 2016;30:409-20.
    PubMed     Text format     Abstract available


  138. KAMEYAMA M, Murakami K, Jinzaki M
    Optimal HMPAO alpha value for Lassen's correction algorithm obscured by statistical noise.
    Ann Nucl Med. 2016;30:445-9.
    PubMed     Text format     Abstract available


    June 2016
  139. PARK SB, Choi JY, Kim HJ, Kim HJ, et al
    Incidental focal 18F-FDG uptake in the frontal process of the maxilla on PET/CT: prevalence and clinical significance.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  140. IDOLAZZI L, Salgarello M, Gatti D, Viapiana O, et al
    Erratum to: 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  141. ARIMOTO MK, Higashi T, Nishii R, Kagawa S, et al
    11C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with 18F-fluorodeoxyglucose PET.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  142. TOYOHARA J, Sakata M, Hatano K, Yanai S, et al
    Preclinical and first-in-man studies of [11C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  143. HAN EJ, Park HL, Lee YS, Park EK, et al
    Clinical usefulness of post-treatment FDG PET/CT in patients with ovarian malignancy.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  144. TERADA T, Yokokura M, Yoshikawa E, Futatsubashi M, et al
    Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  145. JEONG YJ, Son HJ, Yoon HJ, Kang DY, et al
    Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson's disease and normal subjects.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  146. ZOGHI M, Jalilian AR, Niazi A, Johari-Daha F, et al
    Erratum to: Development of a Ga-peptide tracer for PET GnRH1-imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format    


  147. NOBASHI T, Nakamoto Y, Kubo T, Ishimori T, et al
    The utility of PET/CT with Ga-DOTATOC in sarcoidosis: comparison with Ga-scintigraphy.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  148. LEE JJ, Chung JH, Kim SY
    Effect of F-fluorodeoxyglucose extravasation on time taken for tumoral uptake to reach a plateau: animal and clinical PET analyses.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  149. KONINGS R, van Gool MH, Bard MP, Zwijnenburg A, et al
    Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-up.
    Ann Nucl Med. 2016;30:362-8.
    PubMed     Text format     Abstract available


  150. KIM BS, Kim SJ, Pak K
    Diagnostic value of metabolic heterogeneity as a reliable parameter for differentiating malignant parotid gland tumors.
    Ann Nucl Med. 2016;30:346-54.
    PubMed     Text format     Abstract available


  151. ZAVADOVSKY KV, Gulya MO, Lishmanov YB, Lebedev DI, et al
    Perfusion and metabolic scintigraphy with (123)I-BMIPP in prognosis of cardiac resynchronization therapy in patients with dilated cardiomyopathy.
    Ann Nucl Med. 2016;30:325-33.
    PubMed     Text format     Abstract available


    May 2016
  152. ANNUNZIATA S, Cuccaro A, Calcagni ML, Hohaus S, et al
    Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET).
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  153. HIDA K, Nonokuma M, Kuwabara Y, Tani T, et al
    Creation and validation of an I-123 FP-CIT template for statistical image analysis using high-resolution SPECT for parkinsonian patients.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  154. PATHAK KA, Klonisch T, Nason RW, Leslie WD, et al
    FDG-PET characteristics of Hurthle cell and follicular adenomas.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  155. FUJITA W, Matsunari I, Aoki H, Nekolla SG, et al
    Prediction of all-cause death using C-hydroxyephedrine positron emission tomography in Japanese patients with left ventricular dysfunction.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  156. VON EYBEN FE, Kairemo K
    Acquisition with C-choline and F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  157. WATANABE H, Ishii K, Hosono M, Imabayashi E, et al
    Report of a nationwide survey on actual administered radioactivities of radiopharmaceuticals for diagnostic reference levels in Japan.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  158. LUCA I, Matteo S, Davide G, Ombretta V, et al
    18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  159. ICHIHARA H, Onoguchi M, Kikuchi A, Shibutani T, et al
    Evaluation of the subtraction method utilizing posterior view for improving visibility of the sentinel lymph nodes for lymphoscintigraphy in breast cancer.
    Ann Nucl Med. 2016;30:298-308.
    PubMed     Text format     Abstract available


    April 2016
  160. IIZUKA T, Kameyama M
    Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  161. ZOGHI M, Jalilian AR, Niazi A, Johari-Daha F, et al
    Development of a Ga-peptide tracer for PET GnRH1-imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  162. OFUJI A, Mimura H, Yamashita K, Takaki A, et al
    Development of a simple non-invasive microsphere quantification method for cerebral blood flow using I-123-IMP.
    Ann Nucl Med. 2016;30:242-9.
    PubMed     Text format     Abstract available


    March 2016
  163. SHIGEMOTO Y, Suga K, Matsunaga N
    F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  164. TAKESHITA T, Morita K, Tsutsui Y, Kidera D, et al
    The influence of respiratory motion on the cumulative SUV-volume histogram and fractal analyses of intratumoral heterogeneity in PET/CT imaging.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  165. HWANG HS, Han YM, Choi YJ, Koh SH, et al
    Visual and quantitative comparison of F-fluorodeoxyglucose PET/CT findings in the detection of pelvic tumor recurrence in colorectal cancer.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  166. NAKAJIMA K, Matsumoto N, Kasai T, Matsuo S, et al
    Normal values and standardization of parameters in nuclear cardiology: Japanese Society of Nuclear Medicine working group database.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  167. LEE HS, Oh JS, Park YS, Jang SJ, et al
    Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via F-FDG PET/CT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  168. VERGER A, Yagdigul Y, Van Der Gucht A, Poussier S, et al
    Temporal epilepsy lesions may be detected by the voxel-based quantitative analysis of brain FDG-PET images using an original block-matching normalization software.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  169. LIM SM, Kim H, Kang B, Kim HS, et al
    Prognostic value of F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  170. LI P, Liu Q, Wang C, Wang T, et al
    Fluorine-18-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer after surgical resection: a systematic review and meta-analysis.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  171. TANAKA K, Yamamoto Y, Maeda Y, Yamamoto H, et al
    Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Ann Nucl Med. 2016;30:89-96.
    PubMed     Text format     Abstract available


    January 2016
  172. KERAMIDA G, Hunter J, Dizdarevic S, Peters AM, et al
    Heterogeneity of intrahepatic fat distribution determined by F-FDG PET and CT.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  173. DE LUCA S, Fonti R, Camera L, Salvatore B, et al
    Multimodal imaging with F-FDG-PET/CT and In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  174. KOBAYASHI M, Matsunari I, Nishi K, Mizutani A, et al
    Simultaneous acquisition of Tc- and I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.
    Ann Nucl Med. 2016.
    PubMed     Text format     Abstract available


  175. MITOMO O
    Quantification of nonuniform distribution of hemi-lung perfusion in chronic obstructive pulmonary disease.
    Ann Nucl Med. 2016;30:3-10.
    PubMed     Text format     Abstract available


  176. CHIEN KJ, Huang HW, Huang TC, Lee CL, et al
    Assessment of branch pulmonary artery stenosis in children after repair of tetralogy of Fallot using lung perfusion scintigraphy comparison with echocardiography.
    Ann Nucl Med. 2016;30:49-59.
    PubMed     Text format     Abstract available


  177. HARATA N, Yoshida K, Oota S, Fujii H, et al
    (18)F-FDG uptake of the spinal cord was decreased after conventional dose radiotherapy in esophageal cancer patients.
    Ann Nucl Med. 2016;30:35-9.
    PubMed     Text format     Abstract available


  178. SOYDAL C, Kucuk ON, Bilgic S, Ibis E, et al
    Radioembolization with (90)Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors.
    Ann Nucl Med. 2016;30:29-34.
    PubMed     Text format     Abstract available


    December 2015
  179. JAILLARD A, Baillet C, Beron A, Tabibzadeh N, et al
    FDG PET/CT allowing detection and follow-up of tumor cell transplantation.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  180. ISHII S, Shimao D, Hara T, Miyajima M, et al
    Comparison of integrated whole-body PET/MR and PET/CT: Is PET/MR alternative to PET/CT in routine clinical oncology?
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  181. SAGA T, Inubushi M, Koizumi M, Yoshikawa K, et al
    Prognostic value of PET/CT with F-fluoroazomycin arabinoside for patients with head and neck squamous cell carcinomas receiving chemoradiotherapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  182. RAYAMAJHI SJ, Mittal BR, Maturu VN, Agarwal R, et al
    F-FDG and F-FLT PET/CT imaging in the characterization of mediastinal lymph nodes.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  183. KINUYA S
    30th anniversary of Annals of Nuclear Medicine.
    Ann Nucl Med. 2015.
    PubMed     Text format    


  184. KOOPMAN D, van Dalen JA, Stigt JA, Slump CH, et al
    Current generation time-of-flight F-FDG PET/CT provides higher SUVs for normal adrenal glands, while maintaining an accurate characterization of benign and malignant glands.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  185. KREMER R, Peysakhovich Y, Dan LF, Guralnik L, et al
    FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  186. FALLAHI B, Esmaeili A, Beiki D, Oveisgharan S, et al
    Evaluation of Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  187. KITAMURA Y, Kozaka T, Miwa D, Uno I, et al
    Synthesis and evaluation of a new vesamicol analog o-[C]methyl-trans-decalinvesamicol as a PET ligand for the vesicular acetylcholine transporter.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


  188. YAMAMOTO Y, Tasaki Y, Kuwada Y, Ozawa Y, et al
    A preliminary report of breast cancer screening by positron emission mammography.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  189. SENDA M, Yamamoto Y, Sasaki M, Yamane T, et al
    An exploratory efficacy study of the amyloid imaging agent [(18)F]flutemetamol in Japanese Subjects.
    Ann Nucl Med. 2015;29:391-9.
    PubMed     Text format     Abstract available


  190. SOYDAL C, Keskin O, Kucuk ON, Ozkan E, et al
    Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy.
    Ann Nucl Med. 2015;29:426-30.
    PubMed     Text format     Abstract available


    May 2015
  191. OGINO Y, Horiguchi Y, Ueda T, Shiomori T, et al
    A myocardial perfusion imaging system using a multifocal collimator for detecting coronary artery disease: validation with invasive coronary angiography.
    Ann Nucl Med. 2015;29:366-70.
    PubMed     Text format     Abstract available


  192. OKUYUCU K, Kavakli K, Ozaydin S, Karahatay S, et al
    Parathyroid adenoma upstaging the lung cancer.
    Ann Nucl Med. 2015;29:371-4.
    PubMed     Text format     Abstract available


    April 2015
  193. STACY MR, Paeng JC, Sinusas AJ
    The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis.
    Ann Nucl Med. 2015;29:217-23.
    PubMed     Text format     Abstract available


  194. DOROUDI A, Erfani M, Norouzi B, Saadati SM, et al
    Clinical application of ultrasound for preparation of (99m)Tc-sestamibi complex.
    Ann Nucl Med. 2015;29:295-301.
    PubMed     Text format     Abstract available


    January 2015
  195. KUSMIEREK J, Pietrzak-Stelmasiak E, Bienkiewicz M, Woznicki W, et al
    Diagnostic efficacy of parametric clearance images in detection of renal scars in children with recurrent urinary tract infections.
    Ann Nucl Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: